Clinic
Rapid Urgent Care, INC.
Rapid Urgent Care, INC. was paid $17.34M by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoRAPID URGENT CARE, INC.
MANDEVILLE, LA 70471
MANDEVILLE, LA 70471
33aNPI1285970780assigned 01/02/2013
33bProvider typeUrgent Care Clinic/Center
28Total paid$17.34M
24GClaims639,118
24DCodes billed57
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Louisiana
Rank by total paid#7 of 98
Median peer was paid$694K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,248 | $960K | |
| 2019 | 49,293 | $1.58M | |
| 2020 | 83,095 | $2.31M | |
| 2021 | 130,846 | $3.90M | |
| 2022 | 125,184 | $3.15M | |
| 2023 | 129,595 | $3.21M | |
| 2024incomplete | 94,857 | $2.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 68,493 | 59,933 | $3.57M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 86,409 | 73,991 | $3.19M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15% | 48,465 | 43,274 | $2.57M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 11% | 23,200 | 20,836 | $1.85M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.8% | 54,039 | 41,910 | $1.52M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.6% | 32,422 | 26,207 | $1.31M |
| 87634 | 4.6% | 16,313 | 13,045 | $806K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.4% | 82,405 | 39,759 | $768K |
| 87428 | 2.9% | 10,416 | 7,594 | $509K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 36,963 | 29,438 | $355K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 2,948 | 2,598 | $204K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 1,819 | 1,376 | $186K |
45 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 4,914 | $124K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,705 | $75K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 34,597 | $73K |
| 96127 | <1% | 81,494 | $49K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 339 | $27K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 672 | $23K |
| 87807 | <1% | 2,164 | $18K | |
| 81025 | <1% | 3,666 | $16K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 19,613 | $16K |
| 81003 | <1% | 9,036 | $15K | |
| 10060 | <1% | 198 | $11K | |
| 73610 | <1% | 534 | $9K | |
| 73630 | <1% | 422 | $7K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 105 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 272 | $5K |
| 94664 | <1% | 696 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,132 | $4K |
| 73130 | <1% | 212 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,178 | $3K |
| 81001 | <1% | 2,633 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 157 | $3K |
| 0012A | <1% | 106 | $3K | |
| 0011A | <1% | 109 | $3K | |
| 73140 | <1% | 164 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 85 | $2K |
| 12001 | <1% | 14 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 106 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 355 | $584.16 |
| 73110 | <1% | 32 | $548.20 | |
| 86308 | <1% | 150 | $485.12 | |
| 69209 | <1% | 43 | $225.57 | |
| 90714 | <1% | 17 | $221.60 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 203 | $187.07 |
| 82962 | <1% | 45 | $105.31 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 87 | $105.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 51 | $102.99 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,567 | $54.30 |
| 91301 | <1% | 173 | $37.08 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 298 | $20.88 |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 27 | $13.41 |
| 99000 | 0% | 371 | $0.00 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 0% | 39 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 291 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 140 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEASE, EDWARD (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Correct Care, INC. | Covington, LA | $4.25M |
| ST Anne Er Group, LLC | Raceland, LA | $1.92M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.